View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Biologics/Immunotherapy News

SPONSORED CONTENT
Save
SPONSORED CONTENT
February 01, 2024
2 min read
Save

Top news of January: Dupilumab for eosinophilic esophagitis, cell phone allergy, more

Top news of January: Dupilumab for eosinophilic esophagitis, cell phone allergy, more

Healio compiled the most-read news in allergy, asthma and immunology posted in January.

SPONSORED CONTENT
January 29, 2024
2 min read
Save

Most dupilumab use for asthma, CRSwNP categorized as persistent

Most dupilumab use for asthma, CRSwNP categorized as persistent

Researchers characterized the use of dupilumab among a cohort of patients with asthma, chronic rhinosinusitis with nasal polyps or both as persistent in a study published in Annals of Allergy, Asthma & Immunology.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
January 29, 2024
3 min read
Save

Success limited in oral immunotherapy for adults with food allergies

Success limited in oral immunotherapy for adults with food allergies

Adults experienced limited success with oral immunotherapy for food allergies, with about half of a cohort halting treatment within 2 years, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

SPONSORED CONTENT
January 24, 2024
2 min read
Save

Dupilumab safe for long-term use to treat moderate to severe asthma

Dupilumab safe for long-term use to treat moderate to severe asthma

Dupilumab appeared safe for long-term use among patients with moderate to severe asthma or oral corticosteroid-dependent severe asthma, according to data from the TRAVERSE continuation study.

SPONSORED CONTENT
January 23, 2024
3 min read
Save

Asthma exacerbation reductions similar across seasons with dupilumab

Asthma exacerbation reductions similar across seasons with dupilumab

Patients with type 2 inflammation experienced reductions in asthma exacerbations with dupilumab, with no differences between seasons, according to a study published in Annals of Allergy, Asthma & Immunology.

SPONSORED CONTENT
January 22, 2024
5 min read
Save

Peanut immunotherapy uses synthetic peptides for safety, durability

Peanut immunotherapy uses synthetic peptides for safety, durability

An immunotherapy comprising seven synthetic peptides may provide a safe and durable alternative to immunotherapies based on whole peanuts, according to a study published in Allergy.

SPONSORED CONTENT
January 18, 2024
3 min read
Save

Early sublingual immunotherapy for allergic rhinitis reduces risks for allergic asthma

Early sublingual immunotherapy for allergic rhinitis reduces risks for allergic asthma

Children who begin sublingual immunotherapy for allergic rhinitis at age 5 years have less risk for developing allergic asthma than children who begin this treatment later, according to a study published in Allergy.

SPONSORED CONTENT
January 05, 2024
5 min read
Save

Patients on benralizumab for asthma maintain control with reduced corticosteroid doses

Patients on benralizumab for asthma maintain control with reduced corticosteroid doses

Patients who take benralizumab for severe eosinophilic asthma can reduce their inhaled corticosteroid doses while maintaining asthma control for up to 48 weeks, according to a study published in The Lancet.

SPONSORED CONTENT
January 04, 2024
5 min read
Save

Better application of biologics may lead to asthma remission, prevention

Better application of biologics may lead to asthma remission, prevention

ANAHEIM, Calif. — The use of biologics for asthma will grow as physicians better define who will respond to specific treatments, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

SPONSORED CONTENT
December 28, 2023
2 min read
Save

Top asthma stories of 2023

Top asthma stories of 2023

This year’s asthma research covered a broad variety of topics, such as the effect of the family dog’s fur on long-term outcomes, asthma care in prison, fast food restaurants and the Canadian wildfires.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails